Ubrelvy (Ubrogepant): Treating Migraine Attacks

Ubrelvy (ubrogepant) is a prescription medicine for treating a migraine attack, with or without aura, in adults. It is an acute treatment, not a daily preventive. [2]

Your clinician should define when to take it, whether a repeat dose is allowed, and what to do if relief is inadequate. Other medicines and kidney or liver disease can change the instructions.

What Ubrelvy does in an attack plan

Ubrogepant is a gepant: a medicine that blocks the receptor for calcitonin gene-related peptide, or CGRP. [5] An attack medicine aims to help you through an episode; a preventive plan aims to reduce the overall burden of future episodes.

International Headache Society guidance discusses gepants as options when triptans are ineffective, not tolerated, or contraindicated. A clinician should consider the diagnosis, previous treatment responses, health conditions, and access when choosing acute treatment. [4]

If you tried another medicine, explain what happened. “It did not work” might mean no relief, partial relief, pain returning, nausea preventing use, or an unwanted effect. Those are different problems. Include how early you took it and whether you could resume your usual activity.

For the broader treatment framework, read Medicines for Migraine Attacks vs. Prevention.

Ubrelvy dosing: understand your own instructions

The usual labeled dose is 50 mg or 100 mg, with or without food. When appropriate, a second dose can follow at least two hours later; the overall maximum is 200 mg in 24 hours. Some patients have lower limits or cannot repeat a dose. [1]

Safety of treating more than eight migraines in 30 days has not been established. [1]

This is an evidence limit, not a target number of attacks to treat. Tell your clinician if you frequently need rescue treatment rather than increasing use yourself.

How much benefit did studies show?

ACHIEVE II tested treatment of a single moderate or severe migraine attack. At two hours, 21.8% of participants receiving ubrogepant 50 mg were pain-free, compared with 14.3% receiving placebo. Freedom from the participant’s most bothersome associated symptom occurred in 38.9% versus 27.4%, respectively. [3]

Being pain-free is a stricter outcome than getting some relief. The trial supports benefit over placebo, while also showing that many participants were not completely pain-free at two hours. It does not establish superiority over another attack medicine or guarantee that your first treated episode will go well.

Ask how your result will be judged across appropriate treatment attempts. Record whether relief lasted and whether you could return to ordinary activity. A useful follow-up considers those outcomes alongside tolerability and the practicality of taking the medicine.

Interactions can change whether or how you take it

Ubrelvy must not be used with strong CYP3A4 inhibitors, including clarithromycin, ketoconazole, or itraconazole. [2] Strong CYP3A4 inducers should also be avoided. Other enzyme or transporter interactions can require dose changes; with moderate CYP3A4 inhibitors, a repeat dose is avoided within 24 hours. [1]

Give the prescriber and pharmacist your complete list, including nonprescription products and supplements. MedlinePlus specifically flags St. John’s wort and curcumin, and advises discussing grapefruit. [5] “Natural” does not mean irrelevant to an interaction review.

Temporary prescriptions matter too. If you receive a new antibiotic or other medicine, ask whether the existing attack instructions remain suitable before the next Ubrelvy dose. Do not stop another necessary medicine on your own to make a combination possible.

Kidney, liver, pregnancy, and breastfeeding considerations

Severe kidney or liver impairment requires a lower Ubrelvy dose. Use is avoided in end-stage kidney disease. These decisions depend on the actual medical assessment, not whether you currently feel unwell. [1]

Tell your clinician about pregnancy, pregnancy plans, or breastfeeding, and contact them if pregnancy occurs during treatment. [5]

There are insufficient human data to establish pregnancy safety. [1]

A small study found low transfer of a single ubrogepant dose into human milk. It measured drug concentrations rather than establishing safety outcomes in breastfed infants. [6]

Ask for an individual plan before trying to interpret those findings yourself. The discussion should account for your migraine needs and the circumstances of pregnancy or infant feeding.

Side effects and warnings to recognize

Do not take Ubrelvy if you have had a serious allergic reaction to ubrogepant or its ingredients. [5]

Nausea and sleepiness are common side effects. [2] Describe whether either interferes with your ability to use the medicine. If you are sleepy or impaired, avoid driving or activities requiring alertness.

Current safety information also includes:

• Allergic reactions: Stop taking Ubrelvy and get emergency help for trouble breathing or swelling of the face, mouth, tongue, or throat. Reactions can occur after a delay. [2]
• Hypertension: New high blood pressure or worsening existing hypertension can occur. Contact your clinician if blood pressure increases and discuss monitoring. [2]
• Raynaud’s phenomenon: New or worsening circulation problems can cause cold, numb, painful, or discolored fingers or toes. Stop Ubrelvy and contact your clinician if symptoms develop; persistent symptoms need evaluation. [1] [2]

For sudden explosive headache, new weakness, speech trouble, or sudden vision loss, call 911 rather than using an attack medicine to test the cause. [7]

Keep a record that supports the next decision

For each treated attack, note when pain began, when you took the dose, any repeat dose, response at about two hours, recurrence, and unwanted effects. Also record attacks you could not treat because the medicine was unavailable or unsuitable.

Bring the record to follow-up with one or two examples that capture the main problem. If you repeatedly ration tablets because of access, say that directly. If your work schedule makes dosing difficult, explain the obstacle. These details help distinguish a medicine’s effect from the conditions in which you used it.

Frequently asked questions

Does Ubrelvy prevent next month’s migraines?

Ubrelvy does not prevent migraine attacks. If attacks are frequent, discuss the overall plan rather than turning it into a scheduled daily medicine. [5]

Can I always repeat the dose after two hours?

No. Your prescription may have a different repeat-dose limit because of interactions or medical conditions. Confirm the exact rule before you need it during an attack. [5]

What if I need another rescue medicine?

Ask for a written backup plan listing what is appropriate for you and when to use it. Do not assume that every combination suggested online fits your medical history.

Reliable resources and a treatment discussion

See the official Ubrelvy patient website and Drugs.com’s Ubrelvy page for further information.

Eligible adults 18 and older physically located in Florida with appropriate nonurgent headaches can request a TeleHeadache clinical assessment. A clinician determines whether a prescription is appropriate. Medication costs are separate from clinical care, and requesting Ubrelvy does not guarantee prescribing or insurance approval.

Official medication information and further reading

Official Ubrelvy website · Ubrelvy on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.